Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GILEAD SCIENCES, INC. Director's Dealing 2015

Oct 5, 2015

29828_dirs_2015-10-05_72c41646-b37a-414a-9e28-dbfdd35c48de.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-10-01

Reporting Person: Carter Paul Rutherford (EVP Commercial Ops)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-10-01 Common Stock M 180 $26.99 Disposed 48963 Direct
2015-10-01 Common Stock M 1820 $40.56 Disposed 50783 Direct
2015-10-01 Common Stock S 2000 $98.59 Disposed 48783 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-10-01 Non-Qualified Stock Option (right to buy) $26.99 M 180 Disposed 2018-07-30 Common Stock (180) Direct
2015-10-01 Non-Qualified Stock Option (right to buy) $40.56 M 1820 Disposed 2023-02-01 Common Stock (1820) Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.

F3: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.